The Office of the Superintendent of Insurance issued a notice regarding coverage for coronavirus diagnostic testing and treatment, which requires issuers to remove cost barriers to testing and treatment and waive any cost-sharing, including co-pays, deductibles, and coinsurance. The bulletin specifies that carriers are prohibited from balance billing for COVID-19 diagnostic testing when determined to be medically necessary.
For more information, contact NACDS’ Mary Staples at 817-442-1155.